Newsletters - January 2000

An FDA proposal in 1998 stated that supplement labels could not imply any diagnosis, treatment, prevention or cure of a disease or definitive disease symptom. In response to this proposal, the FDA received thousands of letters, from the dietary supplements industry and consumers, petitioning moderation. On January 5, 2000, the FDA conceded a little. Supplements will be allowed to claim to help in the management of ``common conditions'' associated with ``passages of life'' such as pregnancy, menopause, adolescence and aging. However, they should not claim to be useful in the treatment of actual disease conditions. This implies that supplements could claim to ease morning sickness or the common leg swelling of late pregnancy, treat ordinary conditions such as teenage acne and hot flashes associated with menopause but should not claim to treat toxemia or other serious pregnancy complications. While claims to treat joint pain (a symptom of arthritis, a disease) are not permitted, treatment of muscle pain is admissible. ``Mild memory loss associated with aging'' but not real dementia could be claimed to be manageable with the use of supplements.

    VISIT US

  • Sabinsa Canada Inc.
    6800 Kitimat Road, Unit 28,
    Mississauga, ON L5N 5M1
    Canada

  • +1 905-286-6616
  • +1 437-988-1663
  • info@sabinsa.ca

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.